Research demonstrates improved anti-fouling properties in silicones using poly(2-ethyl-2-oxazoline) additives, suggesting a safer alternative to PEG.
• Anti-fouling silicones were created with surface modifying additives (SMAs). • Poly(2-ethyl-2-oxazoline) (PEtOx)-based SMAs were prepared with a siloxane tether. • PEtOx-modified silicones demonstrated resistance to proteins and microorganisms. While silicones are broadly utilized for medical devices, their hydrophobic nature renders them highly prone to biofouling, leading to reduced safety and efficacy. We have previously demonstrated that biofouling is reduced for silicones combined with amphiphilic surface modifying additives (SMAs) comprised of a poly(ethylene glycol) (PEG) segment and a siloxane tether (PEG-silane). However, there is a rising concern regarding the potential immunogenicity of PEG. Herein, SMAs were created wherein poly(2-ethyl-2-oxazoline) (PEtOx) was substituted for PEG. PEtOx-silane SMAs (H-Si-DMS m - block -PEtOx 10 ; m = 13 and 30) were synthesized, and each incorporated into unfilled (i.e., silica-free) silicones: dimethyl silicone [MED-6019; 0% Ph], dimethyl diphenyl silicone [MED-6010; 5.8% Ph], and dimethyl diphenyl silicone [MED-6020; 8.5% Ph] at increasing concentrations (5 – 25 µmol g −1 ). Analogous PEG-silane SMAs (H-Si-DMS m - block -PEG 8 ; m = 13 and 30) were likewise used to modify the silicones. The chemical crosslinking and subsequent retention of SMAs in modified silicones was confirmed. The resulting properties imparted by a particular SMA were impacted by the phenyl content of the silicone. However, PEtOx-based SMAs generally produced a greater plasticizing effect than PEG-based SMAs. Fouling against fibrinogen, a fungus, and four bacteria was assessed for silicones modified with each SMA (25 µmol g −1 ). In general, silicones modified with POx-based SMAs demonstrated greater anti-fouling behavior versus unmodified silicones. DMS 30 -POx often achieved similar anti-fouling efficacy versus PEG-based SMAs. These results point to the potential of amphiphilic POx-based SMAs to produce anti-fouling silicones.
No takes yet. Share an insight, caveat, or question.
Hernández et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: